Refinancing Wall, Covenants and a Negative Rating Outlook
Veltrix Group reports LTM EBITDA of EUR 210 million and net debt of EUR 640 million, a net leverage of 3.05x. Its EUR 500 million revolving credit facility (EUR 180 million drawn) matures in 11 months and carries a covenant of net leverage at or below 3.75x tested semi-annually, plus interest cover of at least 3.0x. A EUR 600 million bond with a 3.25% coupon matures in 22 months, and a EUR 150 million Schuldschein amortises in quarterly instalments. Management plans EUR 120 million of capex and a EUR 60 million dividend next year; free cash flow is expected at EUR 140 million before those items, interest and tax. A bank has offered a 5-year term loan at EURIBOR + 225bp, or a 12-month bridge at +140bp to be refinanced by a bond. The group is rated BBB- with a negative outlook; the agency's guidance flags 3.0x as consistent with the rating, and EURIBOR is 3.6%.
1. Quantify covenant headroom and assess whether the capex and dividend plan fits within it.
Read the worked answer
Headroom at the covenant level: maximum net debt at 3.75x is 3.75 x 210 = EUR 787.5m, so headroom is 787.5 - 640 = EUR 147.5m, or about 0.70x of EBITDA. But the plan consumes most of it. Free cash flow of 140 less capex of 120 less dividend of 60 is negative EUR 40m before interest and tax; add interest and tax and net debt rises towards EUR 690-700m by year-end, or roughly 3.3x. That is inside the covenant but outside the 3.0x level the agency associates with BBB-.
Interest cover is not the binding constraint: interest is roughly 8.3m on the drawn RCF (4.6% all-in), 19.5m on the bond and around 6m on the Schuldschein, about EUR 34m in total, giving coverage of over 6x against a 3.0x requirement. The issue is leverage and the rating, not solvency.
The real covenant risk is the RCF maturity in 11 months. If it is not refinanced, it becomes a current liability at the next test and the lender group's willingness to waive anything disappears. Conclusion: the plan fits within the covenant on current numbers but leaves thin headroom and supports a downgrade; the dividend should be treated as conditional, not committed.
2. Recommend a refinancing structure and instrument, comparing the term loan, the bond, and the bridge.
Read the worked answer
The bridge is the weakest option. At EURIBOR + 140bp it is the cheapest today, but it converts a known 11-month problem into an unknown 12-month one, and with a negative outlook the bond market may be closed exactly when the bridge matures. A bridge is only defensible if the take-out bond is pre-marketed and the group can accept a market-flex outcome.
The 5-year term loan at +225bp (about 5.85% all-in) is priced competitively against where a BBB- bond would clear (likely +250-300bp), provides committed tenor through the 22-month bond maturity, and brings banks into a refinancing that they will want to support if they are also asked to extend the RCF. Its costs are amortisation and tighter maintenance covenants.
Recommended structure: replace the RCF with a new 5-year facility - a smaller undrawn revolver for liquidity plus a EUR 300m term loan that repays the drawn RCF and funds part of the negative free cash flow - and pre-fund the EUR 600m bond at least 12-15 months before maturity with a 7-year issue or a Schuldschein top-up. Two principles drive this: never refinance a maturity inside twelve months, and keep a committed undrawn facility equal to at least three months of peak outflow. To protect the rating, cut or suspend the dividend and phase the capex, moving leverage back toward 3.0x before approaching bond investors.
3. EBITDA is revised down 8% at year-end. Quantify the covenant position and set out the mitigants you would activate.
Read the worked answer
Revised EBITDA is 210 x 0.92 = EUR 193.2m. If net debt lands at EUR 690m, leverage becomes 690 / 193.2 = 3.57x against a 3.75x covenant. Headroom collapses to (3.75 x 193.2) - 690 = 724.5 - 690 = EUR 34.5m, about 0.18x of EBITDA. A single weak working-capital quarter, or a further 2-3% EBITDA miss, breaches the covenant. Interest cover remains comfortable at roughly 5.7x, but the agency threshold of 3.0x is breached by a wide margin, so a downgrade to BB+ is likely, raising future funding costs and potentially triggering collateral or pricing ratchets in the Schuldschein.
Mitigants, in order of speed: suspend the dividend (EUR 60m, does not need lender consent), defer discretionary capex of EUR 30-40m, and release working capital. Check the RCF for equity cure rights - if present, a modest equity injection is the cleanest cure, but cures are typically limited in number and size and cannot be used twice for the same period. A sale-and-leaseback of property or a distribution centre could raise EUR 60-80m within a quarter and is EBITDA-neutral, which is exactly what a leverage covenant needs.
The most important action is timing: open the conversation with lenders at 3.3x with a credible plan, not at 3.8x with a request. A pre-emptive covenant reset or amend-and-extend is materially cheaper than a waiver after a breach.